Intended for healthcare professionals

Letters Renaming low risk cancers

Renaming low risk cancers: honest engagement with patients is more important

BMJ 2019; 364 doi: (Published 26 February 2019) Cite this as: BMJ 2019;364:l840
  1. Santhanam Sundar, consultant oncologist
  1. Nottingham University Hospitals NHS Trust, Nottingham, UK
  1. sundar{at}

Renaming low risk cancers would be a cosmetic exercise and would not solve the underlying problem.1 The exponential rise in diagnosis of low risk cancers …

View Full Text

Log in

Log in through your institution


* For online subscription